false 0001227636 0001227636 2024-02-29 2024-02-29

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 29, 2024

 

 

NEURONETICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38546   33-1051425
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

3222 Phoenixville Pike, Malvern, PA    19355
(Address of Principal Executive Offices)    (Zip Code)

Registrant’s telephone number, including area code: (610) 640-4202

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol

  

Name of each exchange
on which registered

Common Stock, $0.01 par value   STIM   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On February 29, 2024, the Compensation Committee of the Board of Directors (the “Board”) of Neuronetics, Inc. (the “Company”) approved annual cash incentive compensation awards for Stephen Furlong, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, and W. Andrew Macan, the Company’s Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary, in the amounts of $226,341 and $206,747, respectively. In addition, the Compensation Committee recommended that the Board approve an annual cash incentive compensation award for Keith J. Sullivan, the Company’s President and Chief Executive Officer, in the amount of $660,800. The Board considered the Compensation Committee’s recommendation at its meeting on March 1, 2024 and approved the awards. The awards will be paid on or about March 7, 2024.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEURONETICS, INC.
Date: March 6, 2024     By:  

 /s/ W. Andrew Macan

     

Name: W. Andrew Macan

     

Title: EVP, General Counsel, Chief Compliance Officer and Corporate Secretary

v3.24.0.1
Document and Entity Information
Feb. 29, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001227636
Document Type 8-K
Document Period End Date Feb. 29, 2024
Entity Registrant Name NEURONETICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38546
Entity Tax Identification Number 33-1051425
Entity Address, Address Line One 3222 Phoenixville Pike
Entity Address, City or Town Malvern
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19355
City Area Code (610)
Local Phone Number 640-4202
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.01 par value
Trading Symbol STIM
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Neuronetics Charts.
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Neuronetics Charts.